Latest news with #ACLE


Sinar Daily
08-07-2025
- Business
- Sinar Daily
JDT retains status as Malaysia's most valuable football team
This high valuation is attributed to the addition of three heritage players and several quality foreign imports, bringing head coach Xisco Muñoz's squad to 39 players in total. Jairo Da Silva (centre) is currently the second most valuable player in the JDT squad with a market value of RM4.4 million. – Photo: Johor Southern Tigers SHAH ALAM - Super League giants Johor Darul Ta'zim (JDT) have further cemented their status as Malaysia's most valuable football club, with the Southern Tigers now valued at €14.08 million (RM71.8 million), according to the latest figures from football market analysis site Transfermarkt. This high valuation was attributed to the addition of three heritage players and several quality foreign imports, bringing head coach Xisco Muñoz's squad to 39 players in total. The most valuable player in the current JDT lineup was new Harimau Malaya heritage striker Joao Figueiredo, who was valued at €2 million (RM9.96 million) following his confirmed signing with the club. The most valuable player in the current JDT squad is the new Harimau Malaya heritage striker, Joao Figueiredo (left), who is valued at €2 million (RM9.96 million). – Photo: Johor Southern Tigers Brazilian striker Jairo Da Silva ranked second at €900,000 (RM4.4 million), followed by fellow heritage player Jon Irazabal at €600,000 (RM3 million). Hector Hevel, who joined from Portuguese club Portimonense, was estimated to be worth €400,000 (RM2 million). Meanwhile, the most valuable local player in the squad remained JDT's standout star Arif Aiman Mohd Hanapi, a four-time Most Valuable Player at the National Football Awards, with a market value of €650,000 (RM3.2 million). So far, JDT has signed eight new players for the 2025/2026 season: Irazabal, Hevel, Figueiredo, Jairo, Antonio Glauder, Ibrahim Manusi, Moussa Sidibe and Jonathan Silva, with the combined value of these new signings amounting to approximately RM28 million. This aggressive recruitment strategy involving top-tier heritage and foreign players is part of JDT's serious preparations for next season's Asian Champions League Elite (ACLE), the Asean Club Championship (ACC) and domestic competitions in the Malaysian League. The club also released 11 players at the end of last season, including Jese Rodriguez, Alvaro Gonzalez, Jordi Amat, Murilo Henrique, Jonathan Viera, Roque Mesa and Anselmo de Moraes, as well as local players Safiq Rahim, Farizal Marlias, Izham Tarmizi and Ramadhan Saifullah, whose contracts were not renewed. Despite these reinforcements, JDT's current market value has dipped slightly from last season's figure of €17.2 million (RM85.62 million), when the club had bolstered its squad for the ACLE group stage. However, the club's valuation was expected to rise again should JDT continue its pursuit of high-calibre signings in line with its ambitious goal of qualifying for the FIFA Club World Cup in the future. Next season is set to be one of JDT's most challenging yet, with the club competing in three major tournaments namely the Malaysian League, ACC and ACLE. More Like This


New Straits Times
06-07-2025
- Sport
- New Straits Times
DPMM FC to foot travel bill for Super League teams heading to Brunei
KUALA LUMPUR: The Malaysian Football League (MFL) has confirmed that DPMM FC will fully sponsor all Malaysian Super League teams travelling to Brunei during the 2025-2026 season. MFL acting chief executive officer Shazli Shaik said the sponsorship arrangement forms part of a key agreement between MFL and DPMM to ensure the smooth participation of the Brunei-based club in the M-League. Under the agreement, DPMM will cover all travel and accommodation expenses. The move mirrors the support the club previously extended to teams in Singapore's S-League. "One of the most important matters in our agreement with DPMM is this sponsorship," said Shazli after the launch of the official match ball for the 2025-2026 season on Saturday. "DPMM requested that it be implemented for the upcoming season, and they've confirmed Brunei will bear the cost." Shazli clarified that although DPMM will compete in the M-League, the club are not eligible to represent Malaysia in international club competitions - Asian Champions League Elite (ACLE), Asian Champions League 2 (ACL2) and Asean Club Championship (ACC). "If Brunei qualify, they will not represent Malaysia as a national slot holder," he said. At the event, MFL unveiled the official ball for the new season - the PUMA Orbita MFL 1. Shazli also announced that 12 teams have confirmed their home venues, with Darulmakmur Stadium in Kuantan identified as an alternative site should any team face last-minute issues. He revealed that Immigration FC have been given until Monday to confirm their venue, while MFL will travel to Brunei on July 10-11 for a special briefing with DPMM . "Our East Coast zone is settled. The Darulmakmur Stadium will serve as a backup venue if necessary," he said. The 13 teams who will play in the M-League next season are Johor Darul Ta'zim (JDT), Selangor, Penang, Kuching City, Sabah, Terengganu, Negri Sembilan, Kelantan Darul Naim, KL City, Police, DPMM, Melaka and Immigration.


New Straits Times
02-07-2025
- Sport
- New Straits Times
JDT star Afiq claims ACLE Best Assist award
KUALA LUMPUR: Johor Darul Ta'zim (JDT) midfielder Afiq Fazail has earned a rare accolade by winning the Best Assist award for the 2024-2025 Asian Champions League Elite (ACLE) season. The 30-year-old's pinpoint pass in JDT's 3-0 win over Ulsan HD at the Sultan Ibrahim Stadium on Nov 5 last year garnered 32.73 per cent of fan votes on the Asian Football Confederation (AFC) website. Afiq edged a host of top players, including Al-Ahli duo Roberto Firmino and Riyad Mahrez, Al-Hilal's Joao Cancelo and Al-Sadd's Akram Afif. He was also one of only two Southeast Asian players nominated — the other being Thailand's Suphanat Mueanta of Buriram United. In the match against Ulsan, Afiq made an immediate impact after coming on as a substitute in the 88th minute. His lofted pass split the defence and found Bergson da Silva, who controlled the ball brilliantly before slotting it past goalkeeper Jo Hyeon Woo for JDT's third goal. Al-Ahli defender Roger Ibanez came second with 26.71 per cent for his assist against Al Wasl, while Mahrez, the former Manchester City winger, finished third with 20.78 per cent for his assist in the semi-final against Al-Hilal.


New Straits Times
02-07-2025
- Business
- New Straits Times
Club World Cup dream within reach for JDT, says Garcia
KUALA LUMPUR: Johor Darul Ta'zim (JDT) have set their sights on qualifying for the Club World Cup (CWC), with chief executive officer Luis Garcia declaring the goal achievable if the team continue to progress at continental level. Garcia said consistent performances in the AFC Champions League Elite (ACLE) would boost JDT's Asian club ranking and improve their chances of representing Malaysia on the world stage. "With the potential expansion of the CWC, our aim is to consistently reach the latter stages of the ACLE," said Garcia. "This is key to strengthening our position in Asia and flying Malaysia's flag at the highest level of club football." Garcia admitted the mission won't be easy. "Asia's top level demands excellence. We cannot take our foot off the gas if we're to achieve this. Our 2025-26 signings reflect this ambition, and JDT's success will ultimately be a success for Malaysian football." The Southern Tigers have qualified for the ACLE every season since 2019 but have yet to reach the quarter-finals. Four Asian teams — Urawa Red Diamonds, Al-Hilal, Ulsan HD and Al-Ain — are representing the continent in the ongoing Club World Cup in the United States. While three sides exited in the group stage, Saudi Arabia's Al-Hilal caused a major upset by beating Premier League giants Manchester City 4-3 in the last 16 on Tuesday. They will face Brazilian side Fluminense in the quarter-finals on Saturday. Garcia added that JDT are working to meet the vision of club owner Tunku Ismail Sultan Ibrahim, who wants the club to maximise their potential and raise the profile of both Johor and Malaysian football internationally. "As Malaysia's sole representative in the ACLE since 2019, JDT have contributed the bulk of the nation's ranking points in Asia," said Garcia. "This has opened doors for more Malaysian clubs to play in Asia. But to build on that, we must aim higher, stay consistent, and push for greater representation." Last season, JDT signed several former La Liga stars, including Jese Rodríguez, Alvaro Gonzalez, Samu Castillejo, Jonathan Viera and Roque Mesa, in a squad worth nearly RM70 million. However, they were knocked out in the round of 16 by Thailand's Buriram United in a 1-0 loss.


Health Line
27-06-2025
- Health
- Health Line
Cutaneous Lupus Erythematosus (CLE): What to Know
Cutaneous lupus erythematosus (CLE) is an autoimmune disease that affects the skin, causing rashes or sores, usually after sunlight exposure. Treatment options include topical steroids, medications, and preventive measures such as avoiding direct sunlight. CLE is a form of systemic lupus erythematosus (SLE). SLE is a chronic, or long-term, autoimmune condition where the immune system attacks tissues and organs within the body, causing inflammation across multiple organ systems, including: skin joints kidneys blood cells brain heart lungs CLE is a form of lupus that only affects the skin, which has different subtypes depending on the symptoms and presentation. It doesn't cause other symptoms of lupus, but people with CLE may go on to develop symptoms of SLE. People with SLE may first experience skin issues and then develop other symptoms or have other organ systems affected. Of people with SLE, 75% will develop problems with their skin, while 25% of people with SLE initially experience skin issues as their first symptom prior to diagnosis. People with CLE tend to be females between the ages of 20 and 50, and this condition is also more common in Black people or people of African descent. Read on to find out more about diagnosis, symptoms, and possible treatment options for CLE. What are the different types of cutaneous lupus? There are three different types of CLE based on symptoms and presentation. These types include: Acute cutaneous lupus (ACLE): ACLE rashes usually happen over a shorter period of time, tend to come and go quickly, and don't cause permanent scarring. Lots of people who have ACLE typically also live with the form of lupus, SLE, that affects other organs in the body, and not just the skin. The ACLE rashes can be localized, which means someone with ACLE would develop a rash over both of their cheeks and the bridge of their nose called ' the butterfly rash ' or 'malar rash.' This rash is usually red, pink, but can also appear dark purple or dark brown on darker skin, and raised, causing swelling and sometimes itchiness. These rashes can also be generalized, where raised rashes tend to appear all over the body, rather than on the face. These generalized rashes tend to occur in people with SLE. Subacute cutaneous lupus (SCLE): SCLE commonly causes ring-shaped sores or patches on the body. These can be scaly, and their edges are usually very distinct. They don't typically occur on the face or scalp and don't cause skin scarring, like DLE rashes, but may still cause skin discoloration. Some cases of SCLE can be caused or aggravated by the use of certain medications, like proton pump inhibitors and calcium channel blockers. This can even occur months or years after using these drugs. Chronic cutaneous lupus (CCLE): This type of CLE causes permanent scarring from skin lesions. These skin lesions tend to be long term. The most common subtype of chronic cutaneous lupus is called discoid lupus erythematosus (DLE). DLE typically causes disc-shaped rashes on the face, scalp, and ears, but they can appear on other parts of the body as well. These rashes can be persistent and scaly, often red, purple, or brown, and slightly raised above the skin surface. These rashes can cause scarring and skin discoloration, or hair loss on the scalp, where specific areas have been affected by the rash. In rare cases, cancer can develop in DLE sores that have been present for a long time. Other types of CCLE include: What are the symptoms of cutaneous lupus? CLE manifests differently in some people. Symptoms may come and go, accompanied by periods of flare-ups and periods of remission. Symptoms of CLE can be different for everyone depending on the specific subtype they live with, but common symptoms include: red, purple, or dark brown skin rashes on the face, neck, ears, scalp, or other parts of the body rashes with ring-like patterns a swollen rash that occurs across the cheeks and bridge of the nose, which can be red, purple, or dark brown skin discoloration, which involves patches of darker and lighter skin, usually as a result of skin scarring itching skin irritation swelling hair loss due to scarring on the scalp photosensitivity mouth sores swollen skin or discoloration around the nails, or nails that crack and fall off dark or blue-black nails on darker skin tones chapped lips blister-like rash livedo reticularis, a lacy pattern that appears on the skin depressions in the skin hives palms that turn red hard lumps under the skin weak blood flow in the fingers and toes when exposed to cold (Raynaud's phenomenon) What causes cutaneous lupus? The cause of CLE is unknown, but multiple risk factors can make someone more likely to develop the condition. Having any or all of these risk factors does not mean someone will develop lupus. These specific risk factors are more common in people who have developed the condition. Some of these include: certain genes that once activated make it more likely to develop the condition a family history of lupus, especially parents or siblings female sex being Black or of African descent environmental factors including use of certain medications exposure to sunlight smoking viral infections prolonged stress How does a doctor diagnose cutaneous lupus? To diagnose CLE, your doctor or dermatologist may ask questions about your symptoms and have an in-depth conversation about your medical history. They will typically perform a physical examination of your skin, scalp, and nails for potential rashes and sores. They'll check or ask whether you have sores in your mouth or inside your nose, and inquire about any medications you've been taking. They might also ask if you've had recurrent skin issues or other autoimmune diseases. They may also order some tests, including: blood tests, to check for specific proteins in your blood skin biopsy, to analyze a small sample of your skin Diagnosing CLE can take a while, as many of the symptoms can overlap with other skin conditions, so it's important to work together with a specialist who can help. What are the treatment options for cutaneous lupus? CLE is not currently curable, so treatment options revolve around easing symptoms and improving your quality of life. This can include: reducing rashes and sores relieving symptoms like itchiness and pain diminishing flare-ups preventing or treating skin scarring stopping irreversible hair loss Some treatment options for CLE include medications and topical creams such as: corticosteroids tacrolimus ointment retinoid dapsone biologics medications for the immune system, such as methotrexate cyclosporine mycophenolate mofetil To help treat scarring or hyperpigmentation caused by certain types of CLE, your doctor or dermatologist may recommend laser therapy. Healthcare professionals also recommend certain preventive measures such as: avoiding exposure to UV light quitting smoking (if applicable) reducing stress What is the outlook for people with cutaneous lupus? CLE is not curable, but treatment options are available to ease symptoms like swelling and pain and improve the appearance of rashes and sores. Doctors recommend certain preventive measures and lifestyle modifications to reduce the risk of flare-ups. This can involve reducing sun exposure or using sun protection measures, such as broad-spectrum sun lotion or a wide-brimmed hat, to avoid triggering symptoms. Takeaway CLE is a form of lupus that affects the skin. Some people may initially develop symptoms of CLE but will later experience other symptoms that affect multiple organs, such as the kidneys, heart, or lungs. Symptoms may come and go, with periods of remission when you might not experience any symptoms, and flare-ups. CLE is not curable, but topical creams and medications can help relieve symptoms during a flare-up.